Skip to content

Alvotech Sustainability Reports

Alvotech operates as a holding company for a global biopharmaceutical platform. Through its subsidiaries, it develops and manufactures biosimilar medicines for patients worldwide.

Sector: Finance & insurance

Country: Iceland

Exchange: Nasdaq

LEI: 222100DCZBOWV5DZ8372

FIGI: BBG014MBMZZ1

7 reports from 2022 to 2025